Enable Injections

Name: Enable Injections
Address: 2863 East Sharon Road, Cincinnati, OH, 45241, US
Telephone: (513) 326-2800

Home
United States
Cincinnati, OH
Enable Injections

Enable Injections' enFuse® is an investigational on-body system designed to deliver large volumes.

Cincinnati-based Enable Injections is a global healthcare innovation company developing and manufacturing drug delivery systems designed to improve the patient experience. Enable's body-worn enFuse® delivers large-volume therapeutics via subcutaneous administration, with the aim of improving convenience, potentially supporting improved safety outcomes, and advancing healthcare system economics. Fo

r more information, please visit www.enableinjections.com.

*Approved in the United States in combination with a specific drug, more information: https://enableinjections.com/our-products.

06/03/2026

Thank you to everyone who visited our booth at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago! Our team enjoyed meeting so many of you and demonstrating the innovative enFuse® On-Body Injector.

To learn more, please visit: https://enableinjections.com/contact-us/

05/29/2026

In the latest episode of Progress, Potential, and Possibilities, our CCO, Matthew Huddleston shares insights with host Ira Pastor on innovation, leadership, and the future of healthcare technology.

The conversation explores the importance of collaboration, adaptability, and advancing solutions designed to support evolving patient and provider needs.

Watch the full episode here: https://www.youtube.com/watch?v=S3RKrqv2kSs

05/22/2026

We are excited to announce CE Certification of the enFuse® on-body injector and syringe transfer system for use in combination with Aspaveli®, commercialized as ASPAVELI® enFuse® and distributed by Sobi - Swedish Orphan Biovitrum AB (publ)("Sobi") across the European Union.

This certification marks another regulatory milestone for our technology and supports our ongoing global expansion efforts to bring the enFuse system to more patients internationally.

Read more here: https://bit.ly/3PhvbK3

05/20/2026

In a new article published in ONdrugDelivery, our SVP of Global Medical Affairs Mehul Desai, PharmD, MBA, joins authors Michael Hageman, PhD (University of Kansas) and Wei Chen, PhD (WuXi Biologics) exploring why SC conversion for ADCs is so uniquely challenging and how on-body injector technology may offer a path forward.

Learn more about these broader considerations in drug delivery and site-of-care flexibility here: https://lnkd.in/geFNxC7w

05/05/2026

We’re excited to be at ONS Annual Congress next week in San Antonio, Texas! Visit us at Booth #504 for enFuse® demonstrations.

Also, be sure to join Haydon DuMond for his presentation, “United Kingdom Nurse and Pharmacist Preferences for On-Body Injector Technology Versus Traditional Manual Syringes in Large-Volume Subcutaneous Drug Delivery” on Thursday, May 14, 2026, 2:00–2:50 PM
Tower View Registration, Poster Pavilion, Poster Monitor 14.

If you plan to attend ONS, we look forward to connecting. Feel free to reach out to Haydon directly or visit: https://enableinjections.com/contact-us/

See you there!

04/23/2026

The enFuse® on-body injector is designed to allow patients to remain mobile during administration, supporting greater flexibility while receiving therapy. The system is intended to deliver medication subcutaneously through a wearable device that begins administration with the push of a button, without visible needles or external tubing.

Learn more about the enFuse technology here: https://enableinjections.com/technology/

04/09/2026

We’re pleased to announce a strategic partnership with Aptar Digital Health to develop a companion digital solution for the enFuse® On-Body Delivery System.

The solution is designed to support patients and caregivers throughout the injection process and provide tools for engagement before, during, and after administration.

Built with a flexible architecture, it is intended to support pharmaceutical partners across clinical development and commercialization.

Read more here: Lhttps://enableinjections.com/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution/

04/08/2026

Please join us in congratulating Tim Wardle, on being named our newest enFuse® Spirit Award recipient!

Tim consistently demonstrates what it means to live Enable’s core values and has made a strong impact across the organization. When a critical regulatory initiative needed leadership at a key moment, Tim stepped in, while continuing his responsibilities as a Quality Engineer, quickly navigating complex requirements, aligning cross-functional teams, and helping drive the work forward.

His thoughtful approach, reliability, and commitment to teamwork reflect our values of Respect, Performance, Impact, Communication, and Commitment.

Tim, thank you for your dedication, collaboration, and the contributions you bring each day. We’re proud to recognize you and celebrate this well-earned achievement!

03/31/2026

We’re looking forward to participating in the MassMEDIC Impact Symposium in Boston this week.

Our Senior Vice President of Global Medical Affairs & Advocacy, Mehul Desai, PharmD, MBA,will be joining the “Talking Tech” panel on Thursday, April 2 from 1:15 – 2:00 PM at the Renaissance Waterfront Boston Hotel. He will be alongside industry experts discussing where wearable and external medical technologies are headed, from emerging trends to real clinical insights.

Address

2863 East Sharon Road
Cincinnati, OH
45241

Telephone

(513) 326-2800

Website

https://enableinjections.com/

Alerts

Be the first to know and let us send you an email when Enable Injections posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your business to be the top-listed Business in Cincinnati?